Clinical Trials on Unresectable Cutaneous Melanoma in Switzerland
Total 177 results
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
PfizerCompletedMelanoma | Unresectable Metatstatic Cutaneous MelanomaSwitzerland, Germany, France
-
PfizerCompletedMetastatic or Unresectable Cutaneous MelanomaUnited States, Spain, Canada, Italy, United Kingdom, Germany, Korea, Republic of, France, Australia, Czechia, Russian Federation, Turkey, Israel, Netherlands, Greece, Hungary, Japan, Portugal, Argentina, Austria, Belgium, Brazil, Po... and more
-
European Organisation for Research and Treatment...Active, not recruitingCutaneous MelanomaFrance, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain
-
Bristol-Myers SquibbCompletedUnresectable or Metastatic MelanomaUnited States, Germany, Italy, United Kingdom, Canada, Denmark, Netherlands, Spain, Belgium, France, Switzerland, Israel, Austria, Brazil
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
University Hospital, Basel, SwitzerlandAnaveon AGRecruiting
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
University of ZurichCompleted
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Markus JoergerRecruiting
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedMelanoma (Skin)Switzerland
-
Prof. Serge LeyvrazCompleted
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
AmgenCompletedCompletely Resectable Stage IIIB, IIIC, or IVM1a MelanomaUnited States, Poland, France, Russian Federation, Spain, Australia, Greece, Switzerland, Brazil
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic Melanoma Naive to Immune Therapy in Metastatic SettingSwitzerland
-
AmgenNo longer availableUnresected Stage IIIB to IVM1c MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
NovartisCompletedMetastatic MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
Prof. Dr. Silke GillessenTerminated
-
University of Lausanne HospitalsFond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...Suspended
-
University of ZurichCompleted
-
John O. PriorTerminated
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.Terminated
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Centre Hospitalier Universitaire VaudoisRecruitingMetastasis From Malignant Melanoma of Skin (Diagnosis)Switzerland
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
University Hospital Inselspital, BerneCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
Novartis PharmaceuticalsCompletedMetastatic MelanomaSwitzerland, United States
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Institut CurieServier; UNICANCERCompletedUveal MelanomaFrance, Switzerland
-
Hoffmann-La RocheCompletedMalignant MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
OnxeoCompletedMelanomaAustria, France, Germany, Switzerland
-
Delcath Systems Inc.IQVIA BiotechCompletedMelanoma, OcularUnited States, Spain, Italy, Germany, United Kingdom, Switzerland, Belgium, Austria, France
-
University Hospital Inselspital, BerneCompletedMerkel Cell Carcinoma | Malignant MelanomaSwitzerland
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Intraocular MelanomaSwitzerland, Italy, United Kingdom, Poland
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.Active, not recruitingMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Germany, Belgium, Netherlands, United Kingdom, Italy, Portugal, Austria